Your browser doesn't support javascript.
loading
DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?
Smelcerovic, Andrija; Kocic, Gordana; Gajic, Mihajlo; Tomovic, Katarina; Djordjevic, Vukica; Stankovic-Djordjevic, Dobrila; Anderluh, Marko.
Afiliação
  • Smelcerovic A; Department of Chemistry, Faculty of Medicine, University of Nis, Nis, Serbia.
  • Kocic G; Department of Biochemistry, Faculty of Medicine, University of Nis, Nis, Serbia.
  • Gajic M; Department of Pharmacy, Faculty of Medicine, University of Nis, Nis, Serbia.
  • Tomovic K; Department of Pharmacy, Faculty of Medicine, University of Nis, Nis, Serbia.
  • Djordjevic V; Department of Microbiology and Immunology, Faculty of Medicine, University of Nis, Nis, Serbia.
  • Stankovic-Djordjevic D; Department of Microbiology and Immunology, Faculty of Medicine, University of Nis, Nis, Serbia.
  • Anderluh M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Front Pharmacol ; 11: 1185, 2020.
Article em En | MEDLINE | ID: mdl-32848788

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2020 Tipo de documento: Article